Evidence map›Paper›PMID 29222075›Full record

ArticleJMIR medical informatics2017

Examining Tensions That Affect the Evaluation of Technology in Health Care: Considerations for System Decision Makers From the Perspective of Industry and Evaluators.

Laura Desveaux, James Shaw, Ross Wallace, Onil Bhattacharyya, R Sacha Bhatia, Trevor Jamieson

Abstract read
In one paragraph

Article in JMIR medical informatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura DesveauxInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-3429-1865
James ShawInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-9522-0756
Ross WallaceInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-8097-5726
Onil BhattacharyyaInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-5219-7288
R Sacha BhatiaInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-6206-5318
Trevor JamiesonInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-1050-3918

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Virtual technologies have the potential to mitigate a range of challenges for health care systems. Despite the widespread use of mobile devices in everyday life, they currently have a limited role in health service delivery and clinical care. Efforts to integrate the fast-paced consumer technology market with health care delivery exposes tensions among patients, providers, vendors, evaluators, and system decision makers. This paper explores the key tensions between the high bar for evidence prior to market approval that guides health care regulatory decisions and the "fail fast" reality of the technology industry. We examine three core tensions: balancing user needs versus system needs, rigor versus responsiveness, and the role of pre- versus postmarket evidence generation. We use these to elaborate on the structure and appropriateness of evaluation mechanisms for virtual care solutions. Virtual technologies provide a foundation for personalized, patient-centered medicine on the user side, coupled with a broader understanding of impact on the system side. However, mechanisms for stakeholder discussion are needed to clarify the nature of the health technology marketplace and the drivers of evaluation priorities.

Indexed as

evaluationhealthcarepolicytechnology

Identifiers

PMID29222075
PMCPMC5741827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.